Document is current
Any future updates will be listed below
-
Authors
Zöllner, Julia
Finer, Sarah
Linton, Kenneth J.
,
Akhtar, Shaheen
Anwar, Mohammad
Arciero, Elena
Ashraf, Samina
Bidi, Saeed
Breen, Gerome
Broster, James
Chung, Raymond
Collier, David
Curtis, Charles J.
Chaudhary, Shabana
Clinch, Megan
Colligan, Grainne
Deloukas, Panos
Durham, Ceri
Durrani, Faiza
Eto, Fabiola
Finer, Sarah
Gafton, Joseph
Garcia, Ana Angel
Griffiths, Chris
Harvey, Joanne
Heng, Teng
Hodgson, Sam
Huang, Qin Qin
Hurles, Matt
Hunt, Karen A.
Hussain, Shapna
Islam, Kamrul
Iyer, Vivek
Jacobs, Ben
Khan, Ahsan
Lavery, Cath
Lee, Sang Hyuck
Lerner, Robin
MacArthur, Daniel
Malawsky, Daniel
Martin, Hilary
Mason, Dan
Mathur, Rohini
Mazid, Mohammed Bodrul
McDermott, John
Morton, Caroline
Newman, Bill
Owor, Elizabeth
Qureshi, Asma
Rahman, Samiha
Ramachandrappa, Shwetha
Reza, Mehru
Russell, Jessry
Safa, Nishat
Samuel, Miriam
Simpson, Michael
Solly, John
Spreckley, Marie
Stow, Daniel
Taylor, Michael
Trembath, Richard C.
Tricker, Karen
Uddin, Nasir
van Heel, David A.
Walter, Klaudia
Winckley, Caroline
Wood, Suzanne
Wright, John
Zöllner, Julia
van Heel, David A.
Williamson, Catherine
Dixon, Peter H.
-
Funding
Funding for this research was provided by:
National Institute for Health and Care Research (NIHR200254)
- License Information
-
More Information
Article History
Received: 14 December 2022
Accepted: 12 April 2023
First Online: 19 May 2023
Competing interests
: SF receives research funding for Genes & Health from MRC, NIHR, Alnylam Pharmaceuticals, Takeda, Glaxo Smith Kline, Merck, Pfizer, NovoNordisk, Maze Pharmaceuticals, Bristol Myers Squibb. DvH receives research funding for Genes & Health from EU-H2020, NIH, MRC, HEFCE-Catalyst, Wellcome, HDR-UK, Alnylam Pharmaceuticals, Takeda, Glaxo Smith Kline, Merck, Pfizer, NovoNordisk, Maze Pharmaceuticals, Bristol Myers Squibb. CW consults for Mirum and GSK. JZ, PD, and KL have none to declare.
